KS
Kedar Shashikant Gokhale
About Kedar Shashikant Gokhale
Data last updated:
Kedar Shashikant Gokhale is a Whole-Time Director at Serum Institute Of India Private Limited (since 2022), Director at Serum Institute Life Sciences Private Limited (since 2020) and Designated Partner at Kedar Gokhale Advisory Llp (since 2022). The companies operate in Pharma and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹11,015 Cr; the largest is Serum Institute Of India Private Limited at ₹10,854 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 01 Apr 2022 | 1984 | ₹10,854 Cr (FY 2025) | Active | |
| Director | 11 Jul 2020 | 2020 | ₹161 Cr (FY 2025) | Active | |
| Designated Partner | 05 Jan 2022 | 2022 | Active |
Board colleagues of Kedar Shashikant Gokhale
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kedar Shashikant Gokhale
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kedar Shashikant Gokhale
Kedar Shashikant Gokhale currently holds 3 directorships: Serum Institute Of India Private Limited (Whole-Time Director, since 01 Apr 2022, revenue ₹10,854 Cr (FY 2025)); Serum Institute Life Sciences Private Limited (Director, since 11 Jul 2020, revenue ₹161 Cr (FY 2025)); Kedar Gokhale Advisory Llp (Designated Partner, since 05 Jan 2022).
Kedar Shashikant Gokhale was first appointed on 11 Jul 2020 as Director at Serum Institute Life Sciences Private Limited. The most recent appointment on record is 01 Apr 2022 at Serum Institute Of India Private Limited.
The 2 current companies of Kedar Shashikant Gokhale that report revenue have a combined latest revenue of ₹11,015 Cr: Serum Institute Of India Private Limited ₹10,854 Cr (FY 2025); Serum Institute Life Sciences Private Limited ₹161 Cr (FY 2025).
The current boards of Kedar Shashikant Gokhale's companies include Adar Cyrus Poonawalla (Serum Institute Of India Private Limited), Adar Cyrus Poonawalla (Serum Institute Of India Private Limited), Behroze Zavareh Poonawalla (Serum Institute Of India Private Limited), Cyrus Soli Poonawalla (Serum Institute Of India Private Limited), Natasha Adar Poonawalla (Serum Institute Of India Private Limited), Parag Rajendra Deshmukh (Serum Institute Of India Private Limited), among others.